等待開盤 05-29 09:30:00 美东时间
+0.550
+1.38%
今日重点评级关注:Tigress Financial:维持英伟达"强力买入"评级,目标价从360美元升至425美元;康托·菲茨杰拉德:维持DeFi Development"超配"评级,目标价从6美元升至7美元
05-28 19:00
Mizuho analyst Ravi Vaidya maintains CubeSmart (NYSE:CUBE) with a Neutral and raises the price target from $40 to $42.
05-27 21:45
BLUF: CubeSmart’s (NYSE:CUBE) Q1 2026 marked the first positive same-store reve...
05-23 02:23
CubeSmart (CUBE) declares $0.53/share quarterly dividend, in line with previous. Forward yield 5.44% Payable July 15; for shareholders of record July 1; ex-div July 1. See CUBE Dividend Scorecard, Yie...
05-20 13:26
U.S. RESEARCH ROUNDUP-Exxon Mobil, Northrop Grumman, Regeneron Pharmaceuticals May 18 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Exxon Mobil, Northrop Grumman and Regeneron Pharmaceuticals on Monday. HIGHLIGHTS * Ch
05-18 15:15
华盛资讯5月5日讯,CubeSmart公布2026财年Q1业绩,公司Q1营收2.85亿美元,同比增长1.8%,归母净利润0.76亿美元,同比下滑5.0%。
05-05 18:07
今日重点评级关注:Canaccord Genuity:维持Sagimet Biosciences"买入"评级,目标价从28美元升至49美元;HC Wainwright & Co.:维持Fate Therapeutics"买入"评级,目标价从5美元升至7美元
05-05 11:40
Cubesmart ( ($CUBE) ) has provided an update. In May 2026, CubeSmart outlined t...
05-05 06:14
RBC Capital analyst Brad Heffern reiterates CubeSmart (NYSE:CUBE) with a Outperform and maintains $46 price target.
05-04 23:24
华盛资讯5月2日讯,CubeSmart公布2026财年Q1业绩,公司Q1营收2.82亿美元,同比增长3.3%,归母净利润0.83亿美元,同比下滑7.1%。
05-02 05:52